Pierre Fabre S.a.

Pierre Fabre Medicament

P. F. Medicament

Pierre Fabre Cosmetique

Other

Pierre Fabre Sante

Pierre Fabre Dermo-cosmetique

Henri Cousse

Gilbert Mouzin

Antoine Stenger

Jean-Pierre Rieu

Bernard Bonnaud

Silvano Casadio

Jean-Pierre Tarayre

Andre Delhon

Guy Pitet

Jean-Marie Autin

Marie-Therese Trebosc

Pierre Fabre

M Antoine Stenger

Jean-Francois Patoiseau

Francois Fauran

Jacky Tisne-Versailles

Pol Vilain

Jean-Pierre Bali

Marie Charveron

Jean F Patoiseau

Veronique Sales

Dennis C Bigg

Pascal Bordat

Jean-Pierre Raynaud

Lucien Dussourd d'Hinterland

Michel Morre

Sylvano Casadio

Mike Briley

Pitet Guy

Michel Briley

Philippe Chopin

Henri Lauressergues

Jacques Dubois

Jean-Claude Vezin

Yvon Gall

Georges Siegenthaler

Nicole Monteny

Michel JeanJean

Alain Mavon

The invention relates to the use of a lipido-sterolic extract for the production of a medicament which is administered in an isolated manner or in an associated manner, in a simultaneous, separated or staggered manner, with prostatectomy, radiotherapy and/or hormonotherapy in order to prevent and/or treat prostate cancer.

Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer

The present invention relates to a dermatological and/or cosmetological composition which is useful in the treatment of pediculosis, characterized in that it contains a synergic combination of a pyrethroid and of crotamiton. The pyrethroids which are the subject of this composition are more particularly permethrin, bioallethrin, resmethrin, tetramethrin and deltamethrin.

Potentialization of pyrethroid by crotamiton which is useful in the

Dermatological and/or cosmetological composition containing retinoids

Liposomes of thermal waters stabilized in a DNA gel

Formamidine compounds of general formula I ##STR1## in which: R.sub.1 represents H or C.sub.1-4 alkyl,

Thioformamidines, their preparation and use as medicaments

The present invention relates to derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines of the general formula I: ##STR1## and the production thereof. It also concerns pharmaceutical compositions comprising as active principle a compound of general formula I and use thereof for treatment of central nervous system disturbances, especially as an anxiolytic.

Derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines, their

The present invention relates to topical compositions containing caffeine carboxylates with organic bases, which are useful as slenderizing agents and in the treatment of cellulitis, as well as their preparation. The heterogeneous topical compositions of the invention contain, as active principle, a caffeine carboxylic acid which has been salified with a cosmetologically-acceptable organic base, the active principle preferably being present in the form of microparticles or microgranules suspended in a hydroalcoholic gel.

Topical slenderizing formulation containing cafeine carboxylic acid

Thioformamidines, and use as medicaments

The present invention relates to a heterogeneous topical composition comprising microgranules or microparticles of a topically-acceptable caffeine metal carboxylate in a hydroalcoholic gel, as well as its preparation and use. The composition, which can be used as slenderizer and/or in the treatment of cellulitis, comprises a long acting topically-acceptable caffeine metal carboxylate as the active principle, which is present in the form of heterogeneously-distributed microgranules or microparticles, having a diameter of about 0.2 to 2 millimeters, suspended in a hydroalcoholic gel in which they are insoluble, advantageously together with Vitamin E or a derivative thereof.

Heterogeneous topical compositions having a base of microgranules of

The present invention concerns new 5-monoaryl as.-triazin-3-ones substituted in 2-position, a method of preparing them, and their use as medicaments. The compounds according to the present invention have general formula (I) ##STR1## in which: the bond represented by a dashed line indicates the presence of an optional double bond;

5-monoaryl as.-triazin-3-ones substituted in 2-position, and their use

The invention relates to new derivatives of biphenyl primary alcohols, their preparation and use as medicaments useful in the treatment and prevention of atherosclerotic disorders. The new derivatives have the general formula ##STR1## in which X represents a halogen atom, and more particularly chlorine, bromine or fluorine in ortho or meta position,

Lipid- and cholesterol-reducing derivatives of halo-biphenyl primary

The invention concerns halo-biphenyl tertiary alcohols of the general formula: ##STR1## in which: X is chlorine or bromine in ortho or meta position.

Halo-biphenyl tertiary alcohols useful in therapy in the treatment of

2-Alkoxycarbonylalkyl-3-oxo-5,6-diaryl-as-Triazines of the formula I ##STR1## wherein R and R.sub.1, which may be identical or different, represent hydrogen, alkyl, alkoxy, hydroxy, dialkylamino, or halogen,

2-alkoxycarbonylalkyl-3-oxo-5,6-diaryl-as-triazines having utility as

The present invention relates to new 2-(arylalkyloxymethyl)morpholine derivatives, the preparation thereof and their application as drugs which are useful in the treatment of disorders of the central nervous system. The 2-(arylalkyloxymethyl)morpholine derivatives according to the invention correspond to the general formula (I): ##STR1## in which: Ar denotes an aromatic group and more especially the following radicals: ##STR2## in the case where Ar denotes a phenyl radical and R denotes a hydrogen atom, an alkyl, alkoxy or halogen group, a trifluoromethyl radical, a nitro or amino group, a hydroxy group or an arylalkyloxy group.

2-(arylalkyloxymethyl)morpholines and the central nervous system

The present invention concerns new derivatives of 1-aryl 2-aminomethyl cyclopropane carboxylates (Z), their preparation and their use as useful drugs for the treatment of various pains. The new derivatives of the present invention have the general formula I ##STR1## in which: R represents a hydrogen or halogen atom, a C.sub.1 to C.sub.4 lower alkyl group, a C.sub.1 to C.sub.4 lower alkoxy group, or a nitro, amino, sulfamoyl or hydroxy group;

1-Aryl 2-aminomethyl cyclopropane carboxylates (Z)

Growing community of inventors

Castres, France

Henri Cousse